Cell-Type Apoptosis in Lung during SARS-CoV-2 Infection

Area of Science:

• Cellular Biology
• Virology
• Pathology

Background:

• The COVID-19 pandemic highlighted the need to understand acute respiratory distress syndrome (ARDS) pathogenesis.
• The specific mechanisms driving ARDS following SARS-CoV-2 infection are not fully understood.

Purpose of the Study:

• To investigate the role of apoptosis in SARS-CoV-2-induced ARDS.
• To examine apoptosis activation in different cell types within lung tissues.
• To explore potential therapeutic interventions targeting apoptosis.

Main Methods:

• Analysis of postmortem lung sections from COVID-19 patients and non-human primate models.
• Utilized multiple-target immunofluorescence assays and Western blotting.
• Investigated apoptosis in co-culture models involving Vero cells, HUVECs, and BEAS2B cells.

Main Results:

• Both intrinsic and extrinsic apoptotic pathways are activated during SARS-CoV-2 infection.
• SARS-CoV-2 did not induce apoptosis in refractory human bronchial epithelial cells (BEAS2B) or HUVECs.
• Co-infection models showed SARS-CoV-2 induced apoptosis in Vero cells and susceptible HUVECs/BEAS2B cells.
• A novel EPAC1 activator reduced apoptosis in HUVECs in co-culture models.

Conclusions:

• Apoptosis plays a significant role in the pathogenesis of ARDS following SARS-CoV-2 infection.
• Understanding cell-type specific apoptosis is crucial for ARDS research.
• EPAC1 activation presents a potential therapeutic strategy for mitigating SARS-CoV-2-induced ARDS.